OcuLief is tailored for the treatment of AMD, DR and DME by long-term release of anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids for 1-12 months.
Read more…
EyeLief™ implant is a novel sustained-release photo-crosslinked preformed biodegradable implant which can sustain release of therapeutics for 6 months and more.
Read more…